By proceeding, you agree to our Terms of Use and Privacy Policy.
Bringing together both technical and strategic expertise sharing case studies with actionable insights, the 4th RNAi-Based Therapeutics Summit returns to Boston to address the most pressing challenges preventing the widespread adoption of RNAi therapies and tackling targets beyond the liver.
Learn how to deliver siRNA into extrahepatic tissues successfully.
Upskill your knowledge about the strategies for successful scale-up and ways to tackle quick turnaround times to meet the demands for in-person trials.
Deeply understand the delivery mechanisms, including lipid conjugates, and CNS that is expanding the therapeutic target space for siRNA therapies. delivery mechanisms, including lipid conjugates, and CNS that is expanding the therapeutic target space for siRNA therapies.
Experts from large pharma and innovative biotech will showcase insights into novel delivery modalities, next-generation chemistries, and clinical updates.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Make faster and better informed drug development decisions In partnership with the world’s leading drug development experts to help you keep up with the pace of preclinical and clinical research developments.
At ChemGenes, we redefine the limits of scientific discovery, development and commercialization by manufacturing the broadest range of modified chemistries available in today’s market.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.